Vestnik oftalmologiiHumansCorneaCorneal OpacityEnzyme Replacement TherapyHematopoietic Stem Cell Transplantation
[Choice of treatment strategy for corneal opacities in patients with mucopolysaccharidosis type VI].
S V Trufanov, V S Prokopchuk, I A Riks
Published: 202510.17116/oftalma2025141061102
Abstract
Mucopolysaccharidoses (MPSs) are a group of rare disorders caused by inherited defects of lysosomal enzymes, leading to widespread intra- and extracellular accumulation of glycosaminoglycans (GAGs). The use of enzyme replacement therapy (ERT) and hem…
Preview only. Read the full abstract at the source